Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches

Susmita Aryal1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

Sanghyo Park1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

Hyungkyu Park1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

https://orcid.org/0000-0002-9419-3047

Chaewon Park1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

Woo Cheol Kim1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

Deepika Thakur1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, Korea

Young-Joo Won2 Division of Health Administration, College of Software Digital Healthcare Convergence, Yonsei University, Wonju, Gangwon State, 26493, Korea

Jaehong Key1 Department of Biomedical Engineering, Yonsei University, Wonju, Gangwon Province, 26493, KoreaCorrespondence[email protected]

https://orcid.org/0000-0002-3453-2123

show all

Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date